| dc.contributor |
Epicentre, Paris, France. |
|
| dc.creator |
Nathan, N |
|
| dc.creator |
Rose, A M C |
|
| dc.creator |
Legros, D |
|
| dc.creator |
Tiendrebeogo, S R M |
|
| dc.creator |
Bachy, C |
|
| dc.creator |
Bjørløw, E |
|
| dc.creator |
Firmenich, P |
|
| dc.creator |
Guerin, P J |
|
| dc.creator |
Caugant, D A |
|
| dc.date |
2007-06 |
|
| dc.date.accessioned |
2017-01-31T07:09:31Z |
|
| dc.date.available |
2017-01-31T07:09:31Z |
|
| dc.identifier |
Meningitis Serogroup W135 Outbreak, Burkina Faso, 2002. 2007, 13 (6):920-3 Emerging Infect. Dis. |
|
| dc.identifier |
1080-6040 |
|
| dc.identifier |
17553237 |
|
| dc.identifier |
http://hdl.handle.net/10144/17732 |
|
| dc.identifier |
http://fieldresearch.msf.org/msf/handle/10144/17732 |
|
| dc.identifier |
Emerging Infectious Diseases |
|
| dc.identifier.uri |
http://dspace.mediu.edu.my:8181/xmlui/handle/10144/17732 |
|
| dc.description |
In 2002, the largest epidemic of Neisseria meningitidis serogroup W135 occurred in Burkina Faso. The highest attack rate was in children <5 years of age. We describe cases from 1 district and evaluate the performance of the Pastorex test, which had good sensitivity (84%) and specificity (89%) compared with culture or PCR. |
|
| dc.language |
en |
|
| dc.publisher |
Published by Centers for Disease Control (CDC) |
|
| dc.relation |
http://www.cdc.gov/ncidod/eid |
|
| dc.rights |
Archived on this site by permission of CDC |
|
| dc.title |
Meningitis Serogroup W135 Outbreak, Burkina Faso, 2002. |
|